Our results emphasize this anti-cancer role of piceatannol by exhibiting that the capability of piceatannol to restrain melanoma cells growth by partially influencing Bax, Bcl-2 and caspase-3 expression in apoptosis, suggesting that piceatannol could be used for the treatment of melanoma. This evidence concerns the gene CASP3 and cancer.